statistiche ricercatore

MARTIGNONI, EMILIA SILVANA

Distribuzione geografica

Continente	#
NA - Nord America	6.345
EU - Europa	3.580
AS - Asia	1.806
SA - Sud America	158
AF - Africa	80
OC - Oceania	7
Continente sconosciuto - Info sul continente non disponibili	6
Totale	11.982

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.289
IT - Italia	1.736
SG - Singapore	670
UA - Ucraina	618
SE - Svezia	288
VN - Vietnam	283
CN - Cina	263
TR - Turchia	245
HK - Hong Kong	213
FI - Finlandia	193
IE - Irlanda	193
GB - Regno Unito	168
BR - Brasile	135
DE - Germania	124
FR - Francia	100
RU - Federazione Russa	86
NG - Nigeria	68
IN - India	49
CA - Canada	37
BE - Belgio	21
BD - Bangladesh	18
JP - Giappone	17
MX - Messico	11
NL - Olanda	9
AT - Austria	8
ES - Italia	8
AR - Argentina	7
MY - Malesia	7
EU - Europa	6
IQ - Iraq	6
ID - Indonesia	5
PL - Polonia	5
SA - Arabia Saudita	5
ZA - Sudafrica	5
BG - Bulgaria	4
NZ - Nuova Zelanda	4
PK - Pakistan	4
AU - Australia	3
CL - Cile	3
CO - Colombia	3
IL - Israele	3
LT - Lituania	3
PY - Paraguay	3
TH - Thailandia	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
BB - Barbados	2
DK - Danimarca	2
EC - Ecuador	2
HR - Croazia	2
HU - Ungheria	2
JM - Giamaica	2
JO - Giordania	2
KZ - Kazakistan	2
MA - Marocco	2
MD - Moldavia	2
AZ - Azerbaigian	1
BO - Bolivia	1
BW - Botswana	1
CH - Svizzera	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
EG - Egitto	1
GL - Groenlandia	1
GR - Grecia	1
HN - Honduras	1
IM - Isola di Man	1
KG - Kirghizistan	1
KW - Kuwait	1
LB - Libano	1
LK - Sri Lanka	1
LU - Lussemburgo	1
MK - Macedonia	1
NO - Norvegia	1
PE - Perù	1
PH - Filippine	1
QA - Qatar	1
RO - Romania	1
SN - Senegal	1
SV - El Salvador	1
TN - Tunisia	1
TW - Taiwan	1
TZ - Tanzania	1
UZ - Uzbekistan	1
Totale	11.982

Salva come PNG Salva come JPEG

Città	#
Milan	1.301
Fairfield	796
Chandler	587
Jacksonville	463
Woodbridge	442
Ashburn	434
Seattle	371
Singapore	354
Houston	325
San Jose	325
Wilmington	302
Ann Arbor	253
Cambridge	250
Hong Kong	211
Dublin	192
Dallas	166
Chicago	160
Princeton	154
Izmir	145
Nyköping	144
Boardman	104
The Dalles	91
Dong Ket	88
San Mateo	77
Como	70
Rome	69
Abuja	68
Lauterbourg	68
Beijing	61
Dearborn	60
Hanoi	45
San Diego	43
Ho Chi Minh City	41
Ogden	33
Philadelphia	30
Helsinki	27
Los Angeles	26
Santa Clara	23
Norwalk	20
Brussels	19
Düsseldorf	18
Pune	17
São Paulo	17
New York	16
Munich	14
Tokyo	14
Edinburgh	13
London	12
Turku	12
Atlanta	11
Orem	11
Verona	11
Kunming	9
Nanjing	8
San Francisco	8
Hefei	7
Nanchang	7
Amsterdam	6
Auburn Hills	6
Brasília	6
Chennai	6
Guangzhou	6
Mexico City	6
Montreal	6
Stockholm	6
Brooklyn	5
Dhaka	5
Frankfurt am Main	5
Kuala Lumpur	5
New Delhi	5
Toronto	5
Chengdu	4
Chongqing	4
Fuzhou	4
Jinan	4
Johannesburg	4
Milton Keynes	4
Nuremberg	4
Rio de Janeiro	4
Tianjin	4
Belo Horizonte	3
Bolzano	3
Boston	3
Charlotte	3
Columbus	3
Council Bluffs	3
Curitiba	3
Da Nang	3
Fayetteville	3
Hangzhou	3
Hải Dương	3
Kocaeli	3
Madrid	3
Manchester	3
Miami	3
Mumbai	3
Poplar	3
Porto Alegre	3
Redwood City	3
Shanghai	3
Totale	8.817

Salva come PNG Salva come JPEG

Nome	#
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias	237
5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms	211
Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome.	199
Changes of neuroendocrine axes in patients with menstrual migraine.	190
Disordered pupil reactivity in Parkinson's disease.	185
CARDIOVASCULAR AUTONOMIC MODULATION AND ACTIVITY OF CAROTID BARORECEPTORS AT ALTITUDE.	184
Autonomic regulation of heart rate and peripheral circulation: comparison of high altitude and sea level residents.	182
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.	181
Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants.	178
Free plasma catecholamine levels in healthy subjects: a basal and dynamic study.The influence of age.	178
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease	178
The brain as a target for adrenocortical steroids: cognitive implications.	177
"Off" painful dystonia in Parkinson's disease treated with botulinum toxin.	177
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women.	176
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.	176
The association of menstrual migraine with the premenstrual syndrome.	174
Combined response of plasma and platelet catecholamines to different types of short-term stress.	173
Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.	172
Neuroendocrine changes in luteal function in patients with premenstrual syndrome.	171
Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease.	170
Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.	170
High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias.	170
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment	170
Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans.	167
Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection.	167
An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics.	166
Platelet catecholamines in cluster headache.	166
Terguride in fluctuating parkinsonian patients: a double-blind study versus placebo.	164
Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study.	164
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.	164
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's disease.	163
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.	163
Is seborrhea a sign of autonomic impairment in Parkinson's disease?	163
The role of language areas in motor control dysfunction in Parkinson's disease.	162
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA.	162
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo.	161
Functional changes of the basal ganglia circuitry in Parkinson's disease.	160
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detection.	159
Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom Med. 2000 May-Jun;62(3):386-93.	159
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.	158
Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients.	158
Non-hormonal therapy of premenstrual syndrome.	157
Changes in motoneuron excitability of masseter muscle following exteroceptive stimuli in Parkinson's disease.	156
Sleep attacks in Parkinson's disease: a clinical and polysomnographic study.	154
Modifications of local cerebral metabolic rates for glucose and motor behavior in rats with unilateral lesion of the subthalamic nucleus.	154
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study.	154
Modifications of plasma and platelet levels of L-DOPA and its direct metabolites during treatment with tolcapone or entacapone in patients with Parkinson's disease	152
Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients	151
LISURIDE PLUS SELEGILINE IN THE TREATMENT OF EARLY PARKINSON'S DISEASE.	150
Medical healthcare use in Parkinson’s disease: survey in a cohort of ambulatory patients in Italy.	150
Motor complications of Parkinson's disease.	148
Parkinson's disease and reproductive life events.	148
Premenstrual dysphoric disorder and eating disorders.	147
The influence of gender in the evaluation of platelet and plasma catecholamines.	147
Electrophysiological study on jaw-opening reflex recorded from digastric muscle in Parkinson's disease and primary cranial dystonias.	145
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter,crossover, controlled study.	144
Hashimoto's thyroiditis in association with Tolosa Hunt syndrome: a case report.	143
Expression polymorphism of the blood-brain barrier component P-glycoprotein(MDR1) in relation to Parkinson's disease.	143
Active music therapy and Parkinson's disease: methods.	138
Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog Neurobiol. 2000 Sep;62(1):63-88.	138
Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.	137
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation.	134
The autonomic nervous system and hypoxia: mountain medicine.	132
ALTITUDE, EXERCISE, AND MOUNTAIN MEDICINE: LESSONS FROM THE FIELD.	131
CARDIOPRESSOR EFFECTS OF SHORT-TERM TREATMENT WITH CABERGOLINE IN L-DOPA STABLE RESPONDER PARKINSONIAN PATIENTS: RELEVANCE OF POSTPRANDIAL HYPOTENSION.	131
Autonomic disorders in Parkinson's disease.	128
Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease	128
LISURIDE AND BROMOCRYPTINE IN L-DOPA STABLE-RESPONDER PARKINSONIAN PATIENTS: A COMPARATIVE, DOUBLE-BLIND EVALUATION OF CARDIOPRESSOR AND NEUROCHEMICAL EFFECTS.	127
Terguride in stable Parkinson's disease.	123
The effects of physical exercise at high altitude on adrenocortical function in humans.	123
Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.	120
Dihydroergocryptine in the treatment of Parkinson's disease: a six months' double-blind clinical trial.	114
Reproductive life milestones in women with Parkinson's disease.	114
Parkinson's Disease Comorbidity Study Group. Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study.	112
Further characterization of autonomic involvement in multiple system atrophy: a pupillometric study.	111
COMT inhibition and safety.	107
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid.	101
Totale	11.997

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	39.801
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	39.801

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	324	0	0	0	0	0	0	0	0	0	49	109	166
2021/2022	824	93	66	80	112	12	46	28	38	30	116	62	141
2022/2023	1.405	104	89	219	128	93	302	0	172	165	46	59	28
2023/2024	1.987	342	358	334	355	361	88	6	69	47	14	2	11
2024/2025	1.019	2	31	245	31	13	67	11	68	130	61	79	281
2025/2026	1.946	123	100	111	218	287	100	579	71	272	85	0	0
Totale													11.997